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Abstract objective There is a high burden of both diabetes (DM) and tuberculosis (TB) in China, and as DM
increases the risk of TB and adversely affects TB treatment outcomes, there is a need for bidirectional
screening of the two diseases. How this is best performed is not well determined. In this pilot project
in China, we aimed to assess the feasibility and results of screening DM patients for TB within the
routine healthcare setting of ﬁve DM clinics.
method Agreement on how to screen, monitor and record was reached in May 2011 at a national
stakeholders meeting, and training was carried out for staff in the ﬁve clinics in July 2011. Implemen-
tation started in September 2011, and we report on 7 months of activities up to 31 March 2012. DM
patients were screened for TB at each clinic attendance using a symptom-based enquiry, and those
positive to any symptom were referred for TB investigations.
results In the three quarters, 72% of 3174 patients, 79% of 7196 patients and 68% of 4972 patients
were recorded as having been screened for TB, resulting in 7 patients found who were already known
to have TB, 92 with a positive TB symptom screen and 48 of these newly diagnosed with TB as a result
of referral and investigation. All patients except one were started on anti-TB treatment. TB case noti-
ﬁcation rates in screened DM patients were several times higher than those of the general population,
were highest for the ﬁve sites combined in the ﬁnal quarter (774⁄100 000) and were highest in one of the
ﬁve clinics in the ﬁnal quarter (804⁄100 000) where there was intensive in-house training, special
assignment of staff for screening and colocation of services.
conclusion This pilot project shows that it is feasible to carry out screening of DM patients for TB
resulting in high detection rates of TB. This has major public health and patient-related implications.
keywords Tuberculosis, diabetes mellitus, screening, China
Introduction
China is a country with 1.3 billion people (or 18.5% of the
world’s population) that is undergoing rapid development
and urbanisation. As a consequence of this social and
economic change, which is associated with increasing
physical inactivity, an unhealthy diet and obesity, there has
been an escalating epidemic of diabetes mellitus (DM)
(Danaei et al. 2011; International Diabetes Federation
2011; Alcorn & Ouyang 2012). An estimated 11% of
urban people and 3% of rural people above the age of
15 years have DM. A study in a nationally representative
sample of over 46 000 adults found that the prevalence of
DM and pre-diabetes was 9.7% and 15.5%, respectively,
accounting for 92.4 million adults with DM and 148 mil-
lion adults with pre-diabetes (Yang et al. 2010). In this
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with age, was higher in urban than rural areas, and in over
60% of people, the disease was undiagnosed at the time of
the survey. In terms of absolute numbers and given the
size of the population, this makes China one of the highest
DM burden countries in the world.
DM is a well known risk factor for the development of
active TB, doubling or tripling the risk (Stevenson et al.
2007; Jeon & Murray 2008; Dooley & Chaisson 2009;
Ruslami et al. 2010). Patients with TB who have DM also
appear to have worse treatment outcomes than those who
do not have DM, with delays in sputum culture conversion,
and an increased risk of both death and recurrent disease
after successful completion of treatment (Baker et al.
2011). Although China has an excellent national TB
programme, follows the ‘DOTS’ model for TB control and
has had much success in the last 20 years in reducing the
burden of TB, the disease is still a considerable problem. In
2010, there were an estimated one million incident cases
of TB (range 0.9–1.2 million), with 6% of new cases and
26% of retreatment cases thought to be multidrug resistant
(MDR-TB = resistance to both isoniazid and rifampicin)
(WHO 2011).
Given the high burden of TB and DM in China and the
association between the two, DM patients would merit
being screened for TB. In 2011, WHO and the Interna-
tional Union Against Tuberculosis and Lung Disease (The
Union) launched a new ‘Collaborative Framework for the
care and control of Diabetes and Tuberculosis’, with one of
the important activities being the routine implementation
of bidirectional screening of the two diseases (WHO &
IUATLD 2011). However, ways of screening, recording
and reporting for the two diseases in routine healthcare
settings are not well determined, and these knowledge gaps
need to be addressed (Harries et al. 2010a; Jeon et al.
2010).
In China, a standardised procedure of screening DM
patients for TB, a monitoring tool and a quarterly system
of reporting were developed and agreed upon in the ﬁrst
half of 2011 with the implementation starting in the second
half of the year. This article describes the implementation,
results and challenges of screening DM patients for TB
within routine healthcare settings in China.
Methods
This was a prospective observational implementation
project carried out in ﬁve DM clinics within routine health
services in China. As a result of support from the World
Diabetes Foundation (WDF), a national stakeholders
meeting was held in Beijing, China, in May 2011, between
The Union, WHO, the World Diabetes Foundation (WDF)
and national diabetes, non-communicable disease and TB
authorities to review and discuss linkages between DM and
TB, the need for bi-directional screening and the WHO-
Union Collaborative Framework. Broad guidelines for how
the screening should be performed were worked out and
agreed upon, and 5 sites for screening DM patients for TB
were selected. These were Taian Central Hospital; Dingxi
Number 2 Hospital; The Afﬁliated Hospital of Guiyang
Medical College; Jinan Central Hospital; and Shijiazhuang
Number 2 Hospital. The hospitals and their geographic
location in China are shown in Figure 1.
The hospitals were selected because of their geographic
locations (Northwest [Dingxi], Southwest [Guiyang],
Central [Shijiazhuang] and East [Jianan and Taian]); the
high prevalence of active TB in the surrounding commu-
nities; and their degree of urbanisation (provincial capital
with good economic status [Jinan], provincial capital with
poor economic status [Guiyang and Shijiazhuang], midsize
city [Taian] and county [Dingxi]). Details of the hospitals
and the DM clinics, the facilities to which suspected TB
patients were referred for the investigation and diagnosis,
and the local TB case notiﬁcation rates in each of the sites
are shown in Table 1.
In July 2011, a training module was held with healthcare
staff from the 5 sites on standardised guidelines for
screening and referral of patients, and monitoring and
reporting of data. Treatment cards and cohort reporting
forms were developed and printed and distributed to the
study sites. Staff ofﬁcers returned to their health facilities
and provided in-service training for staff working in the
clinics. Implementation of activities started on 1 September
2011. It was agreed that data would be reported in
quarterly cohorts: Q3-2011 (September); Q4-2011 (Octo-
ber to December); and Q1-2012 (January to March), and
that implementers would convene in May 2012 to discuss
results, challenges and ways forward.
Patients included persons aged 14 years and above who
had been diagnosed with DM and who were receiving care
and treatment in the 5 DM clinics from September 2011
to the end of March 2012.
The screening for active TB followed the guidelines of
the China National TB Control Programme (NTP)
(China NTP). Screening was expected to be carried out
every time the patient visited the DM clinic and was based
on asking about ﬁve symptoms: cough for longer than
2 weeks; night sweats for 4 weeks or longer; fever for
4 weeks or longer; weight loss over the previous 4 weeks;
and any suspicion of active TB to account for extrapul-
monary TB (EPTB). If a patient gave an afﬁrmative answer
to any of the ﬁve questions, this was regarded as a positive
symptom screen, and the patient was referred to TB
services for investigation in accordance with the Opera-
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NTP). In brief, investigations and diagnosis of TB were
made using sputum smear microscopy for acid-fast bacilli
and chest radiography. When a diagnosis of active TB was
made, the patient was referred to the NTP for the
registration and treatment. Whether TB was diagnosed or
excluded, patients were expected to be referred back to the
DM clinic for continued care of their DM disease.
Monitoring, recording and reporting
A DM treatment card (Figure 2) was developed for
recording data about the patient’s DM history and current
DM status, and every time the patient came to the clinic
whether screening for TB symptoms had been carried out,
the results of the screening and the results of investigations
if the symptom screen was positive. To trace the DM
Table 1 Details of the 5 hospitals involved in the implementation of TB screening in patients with diabetes
Taian Central
Hospital
Dingxi
Number 2
Hospital
Guiyang Medical
College Hospital
Jinan Central
Hospital
Shijiazhuang
Number 2
Hospital
Number of Hospital Beds 2100 503 2000 1200 670
Number of daily out-patient visits 2000 650 3500 2500 750
Number of daily DM patient visits 40 123 200 60 110
Number of doctors at the DM
clinic
20 33 20 18 15
Number of nurses at the DM clinic 32 72 24 24 25
Main source of Patients Urban and
rural
Rural Urban and rual Urban Urban
To where are TB suspects referred TB and Chest
TumorCenter,
Taian
Anding
District CDC
TB Clinic
TB clinic at the
same hospital
Shandong Chest
Hospital
Shijiazhuang
Number 5
Hospital
Distance of TB clinic from DM
clinic (km)
2 1.0 0 0.5 6.0
TB case notiﬁcation rate⁄100 000
general population
55 73 111 31 63
Five Diabetes Clinics in China 
Dingxi
Shijiazhuang
Jinan
Taian
Guiyang
Figure 1 Locations of the 5 diabetes clinics
in China.
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identiﬁcation card was developed, which was stickered
onto the patient record.
Standardised quarterly report forms were developed and
used for the recording of data. These were compiled by
health clinic staff 30 days after the end of the quarter to
allow for the collection of data from TB Clinics. These
reports were kept at the facilities and also sent to the Union
China Ofﬁce and TB clinical centre of the China Centre for
Disease Control (CDC) for collation. Supervision and site
visits were carried out by staff of the Union China Ofﬁce
and the TB clinical centre of the China CDC during the ﬁrst
period of the study.
Individual patient data were received and cross-checked
by staff of the Union China Ofﬁce and the TB clinical
centre of the China CDC, then double entered to an
EXCEL ﬁle and analysed. Comparisons between groups
were made using the chi-squared test, and odds ratios
(OR) were calculated where appropriate with 95%
conﬁdence intervals (CI). The level of signiﬁcance was set
at 5%.
National authorities in China stated that this was a pilot
project aiming to test the feasibility of the TB screening
approach amongst DM patients with a view to learning
lessons for national scale up. As such, formal ethics
approval in China was deemed not to be necessary.
However, permission to use, report and publish the
collected data was obtained from the Union Ethics Advi-
sory Group, Paris, France.
Results
ResultsforTBscreeninginallﬁvesitescombinedforquarter
3-2011, quarter 4-2011, quarter 1-2012 are shown in
Table 2. Between 68% and 79% of patients with DM were
recorded as having been screened for TB in each of the
quarters. Altogether, from the 15 342 patient-screening
episodes during the study period, 7 patients were identiﬁed
as known to have TB and were receiving anti-TB treatment,
92 (0.6% of those screened) had a positive TB screen, 88
were referred for TB investigations and 48 (55% of those
investigated) were newly diagnosed with TB. All except one
of these patients was started on anti-TB treatment, one
patient being lost to follow up after diagnosis. A total of 55
DM patients (known and new) were identiﬁed with TB: 40
with new and 15 with recurrent TB, and 28 with smear-
positive pulmonary TB, 24 with smear-negative pulmonary
TB and 3 with EPTB. The TB case notiﬁcation rate was
signiﬁcantly higher for quarter 1-2012 (774 per 100 000
DM screened) than for quarter 4-2011 (352 per 100 000
DM screened) – OR 2.2 (95%CI 1.9–2.5, P < 0.001).
The process of screening and referral in Guiyang Medical
College was different from the other four health facilities:
after training, the hospital staff developed a uniform patient
ﬂow chart that was understood by all clinical and nursing
staff in the clinic; clear roles and responsibilities were given
to DM clinic staff; special assigned staff were always
availableforscreeningpatientsforTBsymptomsbeforethey
saw clinic doctors, and these staff recorded results of TB
Diabetes Registration Number____________________
DIABETES TREATMENT CARD AND TUBERCULOSIS SCREENING:  YEAR_________
Name_______________________ Age__________ Sex______________
Date of diagnosis of DM_________________ Type of DM____________ Current  Medication______________________
Quarter Month Date Weight
Kg
Blood
Glucose
Outcome * Medication ** TB Symptom
Screen (Y/N)
Positive TB
Screen
(Y/N)
Referred
for TB
tests
(Y/N)
Diagnosed
with TB
(Y/N)
TB details
Q1
Jan Date of diag-
nosis
TB – type and
category
TB Register
No.
Date of TB
treatment
Feb
Mar
Q2
Apr
May
Jun
Q3
Jul
Aug
Sep
Q4
Oct
Nov
Dec
Figure 2 Diabetes Treatment Card used for screening for active TB. *Outcome: A, alive in care; DIED, dead from any cause; LTFU, lost
to follow up; TO, transferred out. **Medication: Diet: Oral: Insulin.
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clinics were situated close to each other on the same ﬂoor
within the same facility. Results of TB screening in Guiyang
Medical College and in the other four sites combined for
each of the quarters are shown in Table 3. Apart from
quarter-3 2011 (just the month of September), when
screening was ﬁrst started, Guiyang Medical College had
higher TB case notiﬁcation rates per 100 000 DM patients
screened than the other four sites together (P < 0.001). For
each site, these were consistently higher than TB case
notiﬁcation rates observed in the general population in the
catchment areas served by the 5 facilities (Table 1).
Discussion
This is the ﬁrst report from China about routine imple-
mentation of screening DM patients for TB. Although
small numbers of TB patients were identiﬁed in absolute
terms, the TB case notiﬁcation rates per screened popula-
tion were consistently higher than those found in the
general population of the catchment areas of the ﬁve
facilities (range 31–111⁄100 000 population – Table 1)
and compared with the national ﬁgure of 78⁄100 000 in
the general population (WHO 2011).The TB case notiﬁ-
cations for all ﬁve sites combined and for the individual
sites in general improved by the third quarter, possibly
reﬂecting improved clinic performance and better famil-
iarity with screening procedures over time. There was also
one hospital with generally higher TB notiﬁcation rates
compared with the other four, which was associated with
the following screening features: well-conducted training,
clear roles and responsibilities, special staff assigned to
screening and recording of data, easy referral to TB services
facilitated by proximity to the DM clinic, all important
Table 2 Screening of Diabetes Patients for Tuberculosis during each quarter for all ﬁve sites combined
Patients with Diabetes who were screened and diagnosed with Tuberculosis Q3-2011 Q4-2011 Q1-2012
Number of DM patients seen in the clinic in each quarter 3174 7196 4972
Number (%) of DM patients screened at least once for TB symptoms
in each quarter
2300 (72%) 5669 (79%) 3361 (68%)
Number of DM patients already diagnosed with TB from elsewhere 0 1 6
Number of DM patients with a positive TB symptom screen 27 39 26
Number of DM patients referred for TB investigations 25 37 26
Number newly diagnosed with TB after referral for investigations 9 19 20
Total number identiﬁed and registered with TB (known and new) 9 20 26
Smear-positive PTB 3 13 12
Smear-negative PTB 5 7 12
EPTB 102
New TB 51 52 0
Previously treated TB 4 5 6
Number placed on TB Treatment 9 20 25
TB case notiﬁcation rate per 100 000 screened DM patients each quarter 391 352 774
Q, quarter; DM, diabetes mellitus; TB, tuberculosis; PTB, pulmonary tuberculosis; EPTB, extrapulmonary tuberculosis.
Table 3 Screening of Diabetes Patients for Tuberculosis each quarter in Guiyang Medical College and the other four health facilities
Patients with Diabetes who were screened
and diagnosed with Tuberculosis
Guiyang Medical College
Dingxi, Jinan, Sjijiazhua, Taian
Hospitals*
Q3-2011 Q4-2011 Q1-2012 Q3-2011 Q4-2011 Q1-2012
Number of DM patients seen in each quarter 899 1426 714 2275 5770 4258
Number of DM patients screened at least
once for TB symptoms in each quarter
899 1426 714 1401 4243 2647
Number of DM patients diagnosed and
registered with TB
3 9 11 6 11 15
TB case registration rate per 100 000 DM
patients screened per quarter
334 631 804 428 259 567
TB case registration rate per 100 000 general
population
Guiyang (111) Dingxi (73); Jinan (31); Shijiazhuang
(63); Taian (55)
*Results of the four hospitals are combined.
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effectiveness of national scale up.
There were various challenges identiﬁed in the screening
of DM patients for TB. First, in the hospitals where no
special staff had been assigned to DM clinics, the doctors
felt under too much pressure to routinely screen patients,
and in many cases, screening was not performed at all or
not comprehensively performed. This also reﬂects a lack of
understanding of the importance of screening for an
infectious disease amongst a group of patients who are at
higher risk of active disease in the event of infection than
the general population (Stevenson et al. 2007; Jeon &
Murray 2008; Dooley & Chaisson 2009; Ruslami et al.
2010).
Second, even when symptom screening was performed,
almost all sites admitted to under-reporting of a positive
symptom screen, and if there was no suspicion of TB despite
prolongedcough,feverandweightloss,thiswasrecordedas
a negative screen. This would explain the low proportion
with a positive symptom screen (<1%) and the very high
yield of active TB amongst those with a positive symptom
screen (>50%), with doctors just selecting those likely to
have active TB. Chest radiography is commonly used in
China, and although not part of the screening algorithm,
it is possible that some patients were investigated with chest
X-ray before or in parallel with symptom screening, thus
increasing the screening precision. Many DM patients also
didnotunderstandthemeaningofthetermnightsweats,and
this enquiry was invariably scored as negative.
Third, some patients with a positive symptom screen
who were referred to the TB clinics for further investiga-
tion did not go, and without an active tracing system, it
was not possible to ensure attendance.
Fourth, ofthepatientsdiagnosedwithTB,onlyabout5%
had extrapulmonary disease. While this proportion appears
to be low, just under 7% of all nationally reported TB cases
in China in 2010 had EPTB (World Health Organization
2011), so this ﬁnding ﬁts with the wider picture.
Fifth, there was a problem in most sites with knowing
the number of DM patients ever registered. The monitoring
system could capture the number of DM patients attending
the clinic each quarter, and in many cases, these may have
been the same patients who attended the clinic in the
previous quarter. However, because there was no formal
registration of patients as occurs in TB or HIV⁄AIDS
programmes (Libamba et al. 2005), the cumulative number
of patients ever registered, and which increased each
quarter as new patients were added to the pool, was not
known. Hence, it was not possible in this study to obtain
the denominator for DM patients; thus, we used DM
patients screened per quarter to calculate the case notiﬁ-
cation rates per screened patients. The lack of systemic
recording, reporting and follow-up of people with DM in
most developing countries is a serious health system gap
not only for DM care delivery, but also for almost all other
non-communicable diseases (Harries et al.2008).
The strengths of this study are that we implemented
screening within the routine system, and there was no
special budget set aside for the implementation of this
activity. Thus, decisions to continue or to expand depend
entirely on the beneﬁts perceived for patients and public
health. We think that given their higher risk for TB and the
fact that patients with diagnosed DM are anyway much
more likely to attend health facilities, the marginal costs for
an opportunistic symptomatic TB screen performed prop-
erly are likely to be small and to prove cost-effective in
countries with a high double burden of disease.
Limitationsincludesomeoftheproblemsdiscussedabove
and not knowing how comprehensively symptom screening
wasperformed.ComparisonsofTBcasenotiﬁcationratesin
screened DM patients with those from the general popula-
tion are also not strictly valid as the notiﬁcation rates in DM
patients are de facto from active case ﬁnding, while the
general population rates are derived from the usual NTP
procedures of passive case ﬁnding. Measuring the true
prevalence rate of TB amongst DM patients requires more
formal research than can be accomplished through the
routine screening process described here, and both formal
andoperationalresearchusingmycobacterialcultureornew
diagnostic techniques such as Xpert MTB⁄RIF would be
needed (Boehme et al. 2010). We need a better understand-
ingofthecostsincurredbypatientsbybeingreferredtoother
services. Finally, further research to better socio-demo-
graphically characterise patients with DM at higher risk of
TB to further improve yields of positive symptom screening
is required.
While this study shows that it is feasible to screen DM
patients for TB, better performance requires more attention
to detail, a consideration of additional staff to assist with
the workload and possibly electronic medical record
systems to assist with cohort reporting (Douglas et al.
2010; Allain et al. 2011). As is the case with HIV-
associated TB (Harries et al. 2010b; Lawn & Wood 2012),
colocation of DM and TB clinics is essential if efﬁcient and
timely referral is to occur, and this may be difﬁcult to
achieve within an already established hospital structure. A
ﬁnal caveat is that globally about half of all patients with
DM are undiagnosed (International Diabetes Federation
2011), and recent data from China conﬁrm these ﬁndings
at the country level (Yang et al. 2010). The screening
approaches we discuss in this study cannot obviously
address this issue, but routine screening of TB patients for
DM is one way of helping to reduce the undiagnosed
proportion of people with DM.
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ScreeningforactiveTBinDMclinicsshouldleadtoincreased
andearlierdetectionofTB,earlierandbettertreatmentofTB
(which might have gone unrecognised) and improved clinical
outcomes on anti-TB treatment and for routine DM care.
Moreover, identifying TB patients early in DM clinics will
helptoreducetheriskofnosocomialTBtransmissioninthese
settings. Finally, the introduction of active TB screening into
DM care potentially allows the use of the well-established
‘DOTS’ system for monitoring, recording and reporting on
case numbers and their outcomes (Allain et al. 2011).This
mayresultinimproveddataonDMandhelpthoseinvolvedin
policy-making work out the best methods for collecting data
on other non-communicable diseases such as hypertension
and cardiac disease. This should be of beneﬁt not only for
China and also for the global community.
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